全文获取类型
收费全文 | 455篇 |
免费 | 30篇 |
专业分类
儿科学 | 8篇 |
妇产科学 | 10篇 |
基础医学 | 60篇 |
口腔科学 | 2篇 |
临床医学 | 46篇 |
内科学 | 126篇 |
皮肤病学 | 2篇 |
神经病学 | 24篇 |
特种医学 | 3篇 |
外科学 | 118篇 |
预防医学 | 46篇 |
眼科学 | 2篇 |
药学 | 20篇 |
肿瘤学 | 18篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 3篇 |
2021年 | 17篇 |
2020年 | 14篇 |
2019年 | 15篇 |
2018年 | 8篇 |
2017年 | 13篇 |
2016年 | 13篇 |
2015年 | 15篇 |
2014年 | 18篇 |
2013年 | 23篇 |
2012年 | 49篇 |
2011年 | 43篇 |
2010年 | 19篇 |
2009年 | 18篇 |
2008年 | 32篇 |
2007年 | 32篇 |
2006年 | 25篇 |
2005年 | 27篇 |
2004年 | 20篇 |
2003年 | 16篇 |
2002年 | 19篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 9篇 |
1998年 | 5篇 |
1997年 | 2篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1988年 | 1篇 |
1987年 | 4篇 |
1986年 | 1篇 |
1985年 | 1篇 |
排序方式: 共有485条查询结果,搜索用时 31 毫秒
1.
2.
3.
R. J. Bosma A. J. Kwakernaak J. J. Homan van der Heide P. E. de Jong G. J. Navis 《American journal of transplantation》2007,7(3):645-652
Obesity is a risk factor for renal graft loss. Higher body mass index (BMI) in native kidneys is associated with glomerular hyperfiltration. Whether higher BMI in renal transplants is associated with hyperfiltration is unknown. We investigated the impact of BMI on renal hemodynamics 1 year post-transplant. We analyzed glomerular filtration rate (GFR, (125)I-iothalamate) and effective renal plasma flow (ERPF, (131)I-hippurate) in 838 kidney transplants. Data were analyzed for all patients and for the subpopulation without diabetes. Long-term impact of BMI and renal hemodynamics were explored by Cox-regression. With higher BMI GFR and filtration fraction (FF) increased significantly. Multivariate analysis supported impact of BMI on GFR (adjusted r(2) of the model 0.275) and FF (adjusted r(2) of the model 0.158). This association was not explained by diabetes mellitus. On Cox-regression analysis, lower GFR and higher FF were independent determinants of overall graft loss and graft loss by patient mortality. Lower GFR and higher BMI were determinants of death-censored graft loss, with borderline contribution of higher FF. In renal transplants higher BMI is independently associated with higher GFR and FF one year posttransplant, suggesting glomerular hyperfiltration with altered afferent-efferent balance. Mechanisms underlying the long-term prognostic impact of hyperfiltration deserve further exploration. 相似文献
4.
Navis G. J.; Dullaart R. P. F.; Vellenga E.; Elema J. D.; de Jong P. E 《Nephrology, dialysis, transplantation》1994,9(10):1477-1481
POEMS syndrome is a multisystem disorder associated with plasmacell dyscrasias. This report describes a patient with POEMS-associatedrenal disease and reviews the literature on biopsy-proven renalinvolvement in POEMS syndrome. Our patient had glomerulonephritiswith membranoproliferative features on light-microscopy withoutcharacteristic findings on immunofluorescence, and with ultra-structural evidence of glomerular microangiopathy. Ultrastructuralevidence of microangiopathy was also found in vasa nervorum.In 20 other cases of POEMS- associated renal disease, 16 hadglomerular disease. Light-microscopy showed membranoproliferative-likeglomerulopathy in 14 patients and glomerular microan giopathyin two. Ultrastructural evidence of microangi opathy was presentin all 15 patients in whom electron- microscopy was done. Thus,in most patients with POEMS-associated glomerular disease acharacteristic lesion is present with evidence of endothelialinjury. As endothelial damage is also found in endoneural vessels,generalized endothelial injury may play a role in non-renalmanifestations of POEMS syndrome. In previous reviews manifestationsof the POEMS syndrome were similar for patients with or withoutmyeloma. Among patients with biopsy-proven glomerular disease,however, myeloma patients are underrepres ented. Whether thisrepresents a sampling error or has true pathophysiological significanceremains to be established. 相似文献
5.
Kramer AB Ricardo SD Kelly DJ Waanders F van Goor H Navis G 《The Journal of pathology》2005,207(4):483-492
Proteinuria is associated with macrophage-dependent interstitial fibrosis (IF). Osteopontin (OPN), a macrophage chemoattractant, may be involved in the transition of proteinuria to IF but protective properties have also been reported. To elucidate whether OPN may be involved in the proteinuria-induced cascade of tubulointerstitial damage, renal expression of OPN was studied during the development of proteinuria-induced renal damage and during anti-proteinuric intervention with ACE inhibition (ACEi). First, the temporal relationships between proteinuria, interstitial OPN induction, and IF in adriamycin nephrosis (AN), a model of chronic proteinuria-induced renal damage, were studied. Second, the effect of anti-proteinuric treatment on OPN expression was investigated. The time course of OPN induction and markers of renal damage was studied in rats with unilateral AN at 6-week intervals until week 30. In a second study, a renal biopsy was taken 6 weeks after induction of bilateral AN; subsequently, rats were treated with ACEi until termination (week 12). In unilateral AN, proteinuria developed gradually and stabilized at week 10. In proteinuric kidneys, OPN expression was induced from week 12 onwards. Simultaneously, a progressive increase in interstitial macrophages, alpha-smooth muscle actin (alpha-SMA), collagen type III, and focal glomerulosclerosis (FGS) was observed. In bilateral AN, ACEi reduced proteinuria and OPN protein and stabilized fibrosis. In untreated animals, OPN mRNA increased, with stable OPN protein and fibrosis and increased FGS. Thus, in AN, development of proteinuria is followed by up-regulation of OPN along with markers of renal damage. The up-regulation of OPN is reversible by anti-proteinuric treatment without a corresponding reduction in fibrosis. Whereas these data are consistent with a role for OPN in the cascade of transition from proteinuria to fibrosis, intervention with ACEi showed that reduction of OPN does not attenuate established fibrosis. 相似文献
6.
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function 总被引:1,自引:0,他引:1
Buter H Navis GY Woittiez AJ de Zeeuw D de Jong PE 《European journal of clinical pharmacology》1999,54(12):953-958
Objective: We studied the pharmacokinetics and pharmacodynamics of single and multiple doses of candesartan cilexetil 8 mg per day
in hypertensive patients with different degrees of renal function impairment. Candesartan is an angiotensin II subtype 1 (AT1)
receptor antagonist that is administered orally as candesartan cilexetil which is converted in the active compound.
Methods: Twenty-three patients were included, divided into groups according to creatinine clearance (cr cl. group A >60 nl · min−1 · 1.73 m−2, group B 30–60 ml · min−1 · 1.73 m−2 and group C 15–30 ml · min−1 · 1.73 m−2).
Results: Trough serum concentrations of candesartan were higher in group C compared with group A. The values did not increase after
multiple dosing, indicating absence of accumulation. There was a significant negative correlation between the area under the
concentration-time curve extrapolated to time infinity (AUCinf) and the glomerular filtration rate (GFR) indicating a lower renal clearance of candesartan in patients with impaired renal
function. The onset of haemodynamic and hormonal effects was gradual. During the single-dose study blood pressure as well
as plasma renin activity (PRA) and angiotensin II were unchanged at peak. At day 5 of the multiple-dose study blood pressure
was lower and both PRA and angiotensin II were higher compared with baseline.
Conclusion: Although serum trough levels increased during repeated administration and half-life was higher in patients with impaired
renal function, candesartan cilexetil at a dose of 8 mg per day does not lead to drug accumulation in these patients. This
dose is effective in lowering blood pressure and appears to be suitable for patients with renal function impairment.
Received: 3 August 1998 / Accepted in revised form: 19 October 1998 相似文献
7.
8.
ABSTRACT: Mortality is the most widely measured outcome parameter. Improvement of this outcome parameter in critical care is nowadays expected not to come from new technologies or treatment, but from delivering the right care at the right moment in a safe way. The measurement of mortality as an outcome parameter confronts us with a problem in providing follow-up to the results. Especially when proven structure and process interventions are applied already, the cause of a suboptimal performance cannot be deduced easily. One possibility is to evaluate the causes of death and to judge preventability. In this article we explore the opportunities and difficulties of a tool to evaluate preventable mortality in the ICU. 相似文献
9.
Protein tyrosine phosphatases in glioma biology 总被引:1,自引:0,他引:1
Anna C. Navis Monique van den Eijnden Jan T. G. Schepens Rob Hooft van Huijsduijnen Pieter Wesseling Wiljan J. A. J. Hendriks 《Acta neuropathologica》2010,119(2):157-175
Gliomas are a diverse group of brain tumors of glial origin. Most are characterized by diffuse infiltrative growth in the
surrounding brain. In combination with their refractive nature to chemotherapy this makes it almost impossible to cure patients
using combinations of conventional therapeutic strategies. The drastically increased knowledge about the molecular underpinnings
of gliomas during the last decade has elicited high expectations for a more rational and effective therapy for these tumors.
Most studies on the molecular pathways involved in glioma biology thus far had a strong focus on growth factor receptor protein
tyrosine kinase (PTK) and phosphatidylinositol phosphatase signaling pathways. Except for the tumor suppressor PTEN, much
less attention has been paid to the PTK counterparts, the protein tyrosine phosphatase (PTP) superfamily, in gliomas. PTPs
are instrumental in the reversible phosphorylation of tyrosine residues and have emerged as important regulators of signaling
pathways that are linked to various developmental and disease-related processes. Here, we provide an overview of the current
knowledge on PTP involvement in gliomagenesis. So far, the data point to the potential implication of receptor-type (RPTPδ,
DEP1, RPTPμ, RPTPζ) and intracellular (PTP1B, TCPTP, SHP2, PTPN13) classical PTPs, dual-specific PTPs (MKP-1, VHP, PRL-3,
KAP, PTEN) and the CDC25B and CDC25C PTPs in glioma biology. Like PTKs, these PTPs may represent promising targets for the
development of novel diagnostic and therapeutic strategies in the treatment of high-grade gliomas. 相似文献
10.
Correlations between plasma strontium concentration,components of calcium and phosphate metabolism and renal function in type 2 diabetes mellitus 下载免费PDF全文